Follow us on :
In what may be considered highly encouraging and promising news for the supplement industry, Senators Orrin Hatch (R-UT) and Tom Harkin (D-Iowa) have asked FDA Commissioner
Will Congress exempt Pre-Jan. 2007 Dietary Supplements from New Dietary Ingredient (NDI) Regulations? Although we don’t yet know whether this legislation has any legs, on
The industry breathed a temporary sigh of relief when they learned that FDA had extended the comment period for its New Dietary Ingredient (NDI) Draft
While so many in the industry seem to be talking about NDI notifications as the biggest issue facing supplement companies, a recent poll of approximately
Dietary supplement law expert Alan Feldstein presented at the American Herbal Products Association webinar last week to address issues surrounding the FDA’s controversial new draft guidance on
Some insight and clarification offered from FDA but many questions left unanswered The Natural Products Association hosted a Webinar featuring both an audio and video
The General Accountability Office (GAO) recently released a report to Congressional requesters on the issue of whether “FDA should take further actions to improve oversight
Fax: (516) 294-0477
Email: info@supplementcounsel.com
Address: 138 Mineola Blvd,
Mineola, NY 11501